Purna Female Healthcare announced that it has entered into an agreement with new investor Hyloris Pharmaceuticals SA (ENXTBR:HYL) for an aggregate investment of up to €4.3 million on February 5, 2021. The company will receive €1.27 million at signing in its first tranche closing.